市場調査レポート
商品コード
1291421
薬物スクリーニング市場:世界の産業動向、シェア、規模、成長機会、2023-2028年予測Drug Screening Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
薬物スクリーニング市場:世界の産業動向、シェア、規模、成長機会、2023-2028年予測 |
出版日: 2023年05月29日
発行: IMARC
ページ情報: 英文 142 Pages
納期: 2~3営業日
|
世界の薬物スクリーニングの市場規模は、2022年に60億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に7.6%の成長率(CAGR)を示し、2028年までに98億米ドルに達すると予測しています。麻薬密売人や地元の売人の増加、薬物乱用の増加、仮想通貨の普及などが、市場を牽引する主な要因の一つです。
薬物スクリーニングとは、個人の血液、尿、毛髪、唾液を採取して分析し、薬物使用によって残留した汚染物質や化学物質の存在を検出するプロセスを指します。酵素免疫測定法(IA)、ガスクロマトグラフィー(GC)、液体クロマトグラフィー/質量分析法(LC/MS)など、さまざまな検査方法があり、最初の陽性結果をもとに実施される優れた高精度の薬物確認検査です。コカイン、ヘロイン、3,4-メチレンジオキシメタンフェタミン(MDMA)などの違法薬物を含む薬物の使用や誤用を検出するために使用されます。また、さまざまな処方薬の誤用や大量服用を検出するためにも使用されます。薬物スクリーニングは、様々な新薬の効率と安全性を推定するために、薬物の様々な臨床試験で実施されます。また、薬物スクリーニングは、刑事法の執行を目的とした法的な訴追の際にも実施されます。さらに、オピオイド療法を受けているさまざまな患者の乱用可能性や服薬アドヒアランスを調べる際にも使用されます。
現在、正確で自然な結果が得られる薬物スクリーニングに対する需要の高まりは、市場にプラスの影響を与える主な要因の1つとなっています。また、世界中で薬物乱用の事例が増加していることも、市場の成長を後押ししています。また、損失、ストレス、不安に対処するために大衆の間で薬物を利用する傾向が強まっており、市場の見通しを良好なものにしています。これとは別に、若い人たちの間で、同調圧力によるクラブ活動、飲酒、喫煙、薬物使用の動向が高まっていることも、市場の成長に寄与しています。さらに、各国の行政機関は、薬物障害を持つ 促進要因を検出するために、道路脇で定期的に口腔液のスクリーニングを実施する取り組みを行っています。また、重度の中毒者や薬物乱用に苦しむ人々を支援するために、薬物乱用・中毒プログラムを立ち上げています。さらに、薬物の密売人や地元の販売業者が増加し、薬物中毒者に薬物を簡単に提供するようになってきています。また、従来の金融システムとは一線を画す仮想通貨の利用が増加し、世界中の薬物ディーラーやバイヤーに匿名性の向上が認められていることも、市場の成長を後押ししています。
The global drug screening market size reached US$ 6.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.8 Billion by 2028, exhibiting a growth rate (CAGR) of 7.6% during 2023-2028. The growing number of drug traffickers and local dealers, rising cases of substance abuse, and increasing employment of virtual currencies represent some of the key factors driving the market.
Drug screening refers to the process of collecting and analyzing the blood, urine, hair, or saliva of an individual to detect the presence of contaminants and chemicals left behind due to drug usage. It comprises a wide variety of testing methods, such as enzyme immunoassays (IAs), gas chromatography (GC), and liquid chromatography/mass spectrometry (LC/MS), which is a superior and highly accurate drug confirmation test implemented on initial positive results. It is utilized for detecting the use and misuse of drugs, which includes illegal drugs, such as cocaine, heroin, and 3,4-Methylenedioxymethamphetamine (MDMA). It is also employed for detecting the misuse of various prescription medicines which are taken in a different way or in high doses. It is performed in various clinical trials of a drug to estimate the efficiency and safety of various novel drugs. Drug screening is also performed during legal prosecution for criminal law enforcement purposes. Furthermore, it is used in accessing abuse potential and adherence among various patients who are receiving opioid therapy.
At present, the increasing demand for drug screening as it is accurate and provides spontaneous results represents one of the primary factors influencing the market positively. Besides this, rising cases of substance abuse around the world are propelling the growth of the market. In addition, the growing utilization of drugs among the masses to cope with losses, stress, and anxiety is offering a favorable market outlook. Apart from this, the rising trends of clubbing, drinking alcohol, smoking, and doing drugs among young individuals due to peer pressure is contributing to the growth of the market. Additionally, governing agencies of various countries are undertaking initiatives to carry out regular roadside oral fluid screening to detect drug-impaired drivers. They are also launching substance abuse and addiction programs to help severe addicts and individuals suffering from drug abuse. Moreover, there is a rise in the number of drug traffickers and local dealers providing easy access of drugs to addicts. This, coupled with the increasing employment of virtual currencies that operate beyond the traditional financial system, granting improved anonymity to drug dealers and buyers across the globe is supporting the growth of the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global drug screening market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product and service, sample type and end user.
The report has provided a detailed breakup and analysis of the drug screening market based on the product and service. This includes equipment (immunoassay analyzers, chromatography instruments, and breath analyzers); rapid testing devices (urine testing devices and oral fluid testing devices); consumables (assay kits, sample collection cups, calibrators and controls, and others); and laboratory services. According to the report, rapid testing devices (urine testing devices and oral fluid testing devices) represented the largest segment.
A detailed breakup and analysis of the drug screening market based on the sample type has also been provided in the report. This includes urine samples, breath samples, oral fluid samples, hair samples, and others. According to the report, urine samples accounted for the largest market share.
A detailed breakup and analysis of the drug screening market based on the end user has also been provided in the report. This includes hospitals, drug testing laboratories, workplaces, drug treatment centers, pain management centers, personal users, and criminal justice system and law enforcement agencies. According to the report, workplaces accounted for the largest market share.
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for drug screening. Some of the factors driving the North America drug screening market included the growing cases of substance abusive, increasing number of drug dealers, rising black marketing of prescribed drugs, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global drug screening market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, Alfa Scientific Designs Inc., Bio-Rad Laboratories Inc., Dragerwerk AG & Co. KGaA, Laboratory Corporation of America Holdings, Lifeloc Technologies Inc., Omega Laboratories Inc., OraSure Technologies Inc., Psychemedics Corporation, Quest Diagnostics Incorporated, Siemens AG, Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.